Related Experiment Videos
Phase II evaluation of Ly156758 in metastatic breast cancer
A U Buzdar1, C Marcus, F Holmes
1Department of Medical Oncology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston.
Oncology
|January 1, 1988
Abstract:
Fourteen patients with disseminated breast cancer with primary or secondary resistance to tamoxifen were treated with LY156758. There were no complete or partial responses and 1 patient showed a minor response. These data illustrate that LY156758 did not have significant antitumor activity in patients previously treated with tamoxifen therapy.